Patients should avoid unsafe online sources and speak with a qualified medical provider before starting any injectable or oral weight loss medication
Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites
Switching patterns following formulary change Switching from AOM tirzepatide remained rare prior to May 2025, averaging 0.6% of patients who switched to a different GLP-1 in the following month
Bellofiore N, Ellery SJ, Mamrot J, Walker DW, Temple-Smith P, Dickinson H (2017) First evidence of a menstruating rodent: the spiny mouse ( Acomys cahirinus )
Others reported bad breath, diarrhoea, hair loss and heartburn during their weight-loss journey
Some program visits will still require an in-clinic follow-up, even if the appointment begins via telehealth, to complete any necessary lab work or in-person physical exam